We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Aon Issues Unsecured Notes, Gets Rating Actions From Moody's
Read MoreHide Full Article
Aon plc’s (AON - Free Report) recently issued $350 million of 10-year senior unsecured notes have received credit rating from Moody's Investors Service (Moody's). The rating agency has allocated a Baa2 rating these notes. The outlook for the parent company and Aon Corporation remains stable.
With the net proceeds from this offering, the company would pay a part of the remaining commercial paper and also use the funds for general corporate purposes.
Reasons Behind the Ratings
The ratings reflect Aon’s impressive global presence, diversification across clients, regions and products plus skill in providing leading risk, health and retirement solutions to middle-market, national and global clients. Aon has been successfully increasing its EBITDA and credibility via steady buyouts, organic growth and restructuring initiatives since its divestiture of benefits administration and business process outsourcing business in 2017.
These strengths are partially offset by the company’s financial leverage, its capital deployment through dividend payouts and share buybacks besides liabilities from errors and omissions in the delivery of professional services.
Last year, Aon’s divestiture generated proceeds worth more than $3 billion, used by the company along with its cash from operations to pay for 17 acquisitions in the period. During the first nine months of 2018, the company closed five buyouts along with 4% organic growth.
The credit rating agency estimates Aon to have a debt-to-EBITDA ratio in the range of 3x-3.5x and (EBITDA-capex) coverage of interest in the 5x-7x band for 12 months through September 2018.
Factors That Can Change the Ratings
The rating upgrade is possible if the debt-to-EBITDA ratio lies below 3x, (EBITDA - capex) coverage of interest is consistently above 6x and net profit margin is steadily above 9%.
Notably, factors that can cause a rating downgrade are debt-to-EBITDA ratio coming in above 3.5x, (EBITDA - capex) coverage of interest falling below 4x or net profit margin is lower than 6%.
Shares of this Zacks Rank #3 (Hold) company have rallied 15% in a year’s time, outperforming its industry’s growth of 7.7%.
Stocks to Consider
Investors looking for some better-ranked stocks from the insurance industry may take a look at Cigna Corporation (CI - Free Report) , eHealth, Inc. (EHTH - Free Report) and Willis Towers Watson Public Limited Company .
Cigna provides insurance and related products and services in the United States and internationally. The stock sports a Zacks Rank #1 (Strong Buy) and pulled off average four-quarter earnings surprise of 13.46%. You can see the complete list of today’s Zacks #1 Rank stocks here.
eHealth offers private online health insurance exchange services in the United States and China. The company has a Zacks Rank #2 (Buy) and came up with average three-quarter beat of 7.29%.
Willis Towers works as an advisory, broking and solutions company worldwide. The company carries a Zacks Rank of 2 and managed to deliver positive surprises in the trailing four reported quarters, the average being 7.13%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Aon Issues Unsecured Notes, Gets Rating Actions From Moody's
Aon plc’s (AON - Free Report) recently issued $350 million of 10-year senior unsecured notes have received credit rating from Moody's Investors Service (Moody's). The rating agency has allocated a Baa2 rating these notes. The outlook for the parent company and Aon Corporation remains stable.
With the net proceeds from this offering, the company would pay a part of the remaining commercial paper and also use the funds for general corporate purposes.
Reasons Behind the Ratings
The ratings reflect Aon’s impressive global presence, diversification across clients, regions and products plus skill in providing leading risk, health and retirement solutions to middle-market, national and global clients. Aon has been successfully increasing its EBITDA and credibility via steady buyouts, organic growth and restructuring initiatives since its divestiture of benefits administration and business process outsourcing business in 2017.
These strengths are partially offset by the company’s financial leverage, its capital deployment through dividend payouts and share buybacks besides liabilities from errors and omissions in the delivery of professional services.
Last year, Aon’s divestiture generated proceeds worth more than $3 billion, used by the company along with its cash from operations to pay for 17 acquisitions in the period. During the first nine months of 2018, the company closed five buyouts along with 4% organic growth.
The credit rating agency estimates Aon to have a debt-to-EBITDA ratio in the range of 3x-3.5x and (EBITDA-capex) coverage of interest in the 5x-7x band for 12 months through September 2018.
Factors That Can Change the Ratings
The rating upgrade is possible if the debt-to-EBITDA ratio lies below 3x, (EBITDA - capex) coverage of interest is consistently above 6x and net profit margin is steadily above 9%.
Notably, factors that can cause a rating downgrade are debt-to-EBITDA ratio coming in above 3.5x, (EBITDA - capex) coverage of interest falling below 4x or net profit margin is lower than 6%.
Shares of this Zacks Rank #3 (Hold) company have rallied 15% in a year’s time, outperforming its industry’s growth of 7.7%.
Stocks to Consider
Investors looking for some better-ranked stocks from the insurance industry may take a look at Cigna Corporation (CI - Free Report) , eHealth, Inc. (EHTH - Free Report) and Willis Towers Watson Public Limited Company .
Cigna provides insurance and related products and services in the United States and internationally. The stock sports a Zacks Rank #1 (Strong Buy) and pulled off average four-quarter earnings surprise of 13.46%. You can see the complete list of today’s Zacks #1 Rank stocks here.
eHealth offers private online health insurance exchange services in the United States and China. The company has a Zacks Rank #2 (Buy) and came up with average three-quarter beat of 7.29%.
Willis Towers works as an advisory, broking and solutions company worldwide. The company carries a Zacks Rank of 2 and managed to deliver positive surprises in the trailing four reported quarters, the average being 7.13%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>